Evidence map›Paper›PMID 29986436›Full record

ReviewMaterials (Basel, Switzerland)2018

Surface Modifications of Nanoparticles for Stability in Biological Fluids.

Luca Guerrini, Ramon A Alvarez-Puebla, Nicolas Pazos-Perez

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed.

  1. Review
  2. Article
  3. Streptavidin-DisplayingSensors (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luca GuerriniDepartamento de Quimica Fisica e Inorganica and EMaS, Universitat Rovira i Virgili Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain. luca.guerrini@urv.cat.
Ramon A Alvarez-PueblaDepartamento de Quimica Fisica e Inorganica and EMaS, Universitat Rovira i Virgili Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain. ramon.alvarez@urv.cat.
Nicolas Pazos-PerezDepartamento de Quimica Fisica e Inorganica and EMaS, Universitat Rovira i Virgili Carrer de Marcel•lí Domingo s/n, 43007 Tarragona, Spain. nicolas.pazos@urv.cat.ORCID 0000-0002-2326-4231

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the high surface: volume ratio and the extraordinary properties arising from the nanoscale (optical, electric, magnetic, etc.), nanoparticles (NPs) are excellent candidates for multiple applications. In this context, nanoscience is opening a wide range of modern technologies in biological and biomedical fields, among others. However, one of the main drawbacks that still delays its fast evolution and effectiveness is related to the behavior of nanomaterials in the presence of biological fluids. Unfortunately, biological fluids are characterized by high ionic strengths which usually induce NP aggregation. Besides this problem, the high content in biomacromolecules—such as lipids, sugars, nucleic acids and, especially, proteins—also affects NP stability and its viability for some applications due to, for example, the formation of the protein corona around the NPs. Here, we will review the most common strategies to achieve stable NPs dispersions in high ionic strength fluids and, also, antifouling strategies to avoid the protein adsorption.

Indexed as

antifoulingbiological fluidscolloidal stabilitymagnetismnanoparticlesplasmonicsprotein coronaquantum dotssurface modification

Identifiers

PMID29986436
PMCPMC6073273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.